KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Cash & Equivalents (2016 - 2025)

Evolent Health has reported Cash & Equivalents over the past 11 years, most recently at $151.9 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $151.9 million for Q4 2025, up 45.73% from a year ago — trailing twelve months through Dec 2025 was $151.9 million (up 45.73% YoY), and the annual figure for FY2025 was $151.9 million, up 45.73%.
  • Cash & Equivalents for Q4 2025 was $151.9 million at Evolent Health, up from $116.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for EVH hit a ceiling of $266.3 million in Q4 2021 and a floor of $96.6 million in Q3 2024.
  • Median Cash & Equivalents over the past 5 years was $174.8 million (2023), compared with a mean of $176.0 million.
  • Biggest five-year swings in Cash & Equivalents: soared 247.34% in 2021 and later crashed 47.66% in 2024.
  • Evolent Health's Cash & Equivalents stood at $266.3 million in 2021, then fell by 29.32% to $188.2 million in 2022, then grew by 2.46% to $192.8 million in 2023, then crashed by 45.96% to $104.2 million in 2024, then soared by 45.73% to $151.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $151.9 million (Q4 2025), $116.7 million (Q3 2025), and $151.0 million (Q2 2025) per Business Quant data.